LSTA FY 2009 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+13743.5% YoY

Gross Profit

$4M34.4% margin

Operating Income

-$26M-223.7% margin

Net Income

-$26M-226.3% margin

EPS (Diluted)

$-3660.00

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$11M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$106M

Total Liabilities

$46M

Stockholders' Equity

$25M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$83,541	+13743.5%
Gross Profit	$4M	$51,562	+7615.0%
Operating Income	-$26M	-$9M	-180.2%
Net Income	-$26M	-$9M	-183.2%